Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

134
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
134
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

74
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
74
Exercise Stress Test01:26

Exercise Stress Test

192
Introduction
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
192

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiple 24-Hour Urinary Sodium and Potassium Excretions and Type 2 Diabetes Incidence.

Diabetes care·2026
Same author

Classification and Severity Assessment of Obesity in Clinical Risk Prediction of Multimorbidity Trajectories.

Clinical obesity·2026
Same author

Metabolic health and cardiovascular outcomes in treated hypertension: a secondary analysis of SPRINT.

Clinical hypertension·2026
Same author

Potential Mediators of Efpeglenatide's Cardiovascular Benefit: An Exploratory Analysis of the AMPLITUDE-O Trial.

Diabetes, obesity & metabolism·2026
Same author

Heart Rate, Electrocardiographic Subclinical Myocardial Injury, and Long-Term Mortality.

Journal of clinical medicine·2026
Same author

Plasma GDF15 affects long-term dementia risk and alters neuroimmune signaling.

Science advances·2026

Related Experiment Video

Updated: Jun 22, 2025

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
07:40

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training

Published on: October 10, 2019

7.3K

High-Sensitivity Troponin T, NT-proBNP, and Cognitive Outcomes in SPRINT.

Devin Haney1, Yuan Ma2, Djhenne Dalmacy1

  • 1Department of Internal Medicine, University of Texas at Tyler Health Science Center (D.H., D.D., J.D.B.).

Hypertension (Dallas, Tex. : 1979)
|July 3, 2024
PubMed
Summary

Lower cardiac biomarker levels in hypertensive adults may enhance cognitive benefits from intensive blood pressure management. Intensive treatment showed a greater risk reduction for cognitive impairment in those with lower hs-cTnT and NT-proBNP levels.

Keywords:
biomarkerscognitiondementiahypertensionnatriuretic peptidestroponin T

More Related Videos

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

2.9K
Revised and Neuroimaging-Compatible Versions of the Dual Task Screen
07:52

Revised and Neuroimaging-Compatible Versions of the Dual Task Screen

Published on: October 5, 2020

3.5K

Related Experiment Videos

Last Updated: Jun 22, 2025

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
07:40

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training

Published on: October 10, 2019

7.3K
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

2.9K
Revised and Neuroimaging-Compatible Versions of the Dual Task Screen
07:52

Revised and Neuroimaging-Compatible Versions of the Dual Task Screen

Published on: October 5, 2020

3.5K

Area of Science:

  • Cardiology
  • Neurology
  • Gerontology

Background:

  • Hypertension management is crucial for preventing cognitive decline.
  • Cardiac biomarkers, including highly sensitive cardiac troponin T (hs-cTnT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP), may stratify risk in hypertensive individuals.
  • Previous research suggests a link between cardiac biomarkers and cognitive function.

Purpose of the Study:

  • To investigate the association between baseline cardiac biomarker levels and the risk of mild cognitive impairment (MCI) or probable dementia (PD) in hypertensive adults.
  • To determine if intensive blood pressure lowering provides differential cognitive benefits based on hs-cTnT and NT-proBNP levels within the SPRINT MIND study.

Main Methods:

  • Utilized data from the SPRINT MIND study, categorizing 8111 participants based on hs-cTnT and NT-proBNP tertiles.
  • Assessed the composite outcome of MCI or PD over a median follow-up of 5.1 years.
  • Compared the effects of intensive versus standard blood pressure treatment on cognitive outcomes across biomarker categories.

Main Results:

  • Participants in the highest cardiac biomarker category had a higher risk of developing MCI or PD (HR, 1.34).
  • Intensive blood pressure treatment showed a significantly greater risk reduction for MCI or PD in the lowest biomarker tertile (HR, 0.64; P interaction=0.02).
  • Absolute risk reductions in MCI or PD with intensive treatment were comparable across biomarker categories, despite differing relative effects.

Conclusions:

  • The relative benefit of intensive systolic blood pressure lowering on cognitive function appears more pronounced in hypertensive individuals with lower cardiac biomarker levels.
  • While relative effects differ, absolute risk reductions for cognitive impairment were similar across biomarker groups.
  • Hs-cTnT and NT-proBNP may help identify hypertensive patients who are more likely to benefit cognitively from aggressive blood pressure control.